Journal article : Editorial

Treatment strategies for patients with spinal muscular atrophy

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

De Waele, L., & Servais, L. (2024). Treatment strategies for patients with spinal muscular atrophy. Expert Review of Neurotherapeutics, 25(3), 259–261.

MLA Style

De Waele, L, and L Servais. “Treatment Strategies for Patients with Spinal Muscular Atrophy.” Expert Review of Neurotherapeutics, vol. 25, no. 3, 2024, pp. 259–61.

Chicago Style

De Waele, L, and L Servais. 2024. “Treatment Strategies for Patients with Spinal Muscular Atrophy.” Expert Review of Neurotherapeutics 25 (3): 259–61.
Print

Access Document

Files:: De_Waele_and_Servais_2024_Treatment_strategies_for.pdf

(Preview, Accepted manuscript, pdf, 1.4MB, Terms of use)

Publisher copy:: 10.1080/14737175.2024.2439486

Authors

+ De Waele, L More by this author

Role:: Author

+ Servais, L More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Paediatrics
Oxford college:: Kellogg College
Role:: Author
ORCID:: 0000-0001-9270-4061

Publisher:: Taylor & Francis
Journal:: Expert Review of Neurotherapeutics More from this journal
Volume:: 25
Issue:: 3
Pages:: 259-261
Place of publication:: England
Publication date:: 2024-12-10
DOI:: 10.1080/14737175.2024.2439486
EISSN:: 1744-8360
ISSN:: 1473-7175
Pmid:: 39648756

Language:: English
Keywords:: risdiplam

gene therapy

spinal muscular atrophy

nusinersen

myostatin
Subtype:: Editorial
Pubs id:: 2070890
UUID:: uuid_d656540b-af39-4bec-b680-d8644ecdafc6
Local pid:: pubs:2070890
Source identifiers:: W4405198426
Deposit date:: 2025-11-12
ARK identifier:: ark:/29072/ora_d656540baf394becb680d8644ecdafc6

Terms of use

Copyright holder:: Informa UK Limited
Copyright date:: 2024
Rights statement:: © 2024 Informa UK Limited, trading as Taylor & Francis Group
Notes:: The author accepted manuscript (AAM) of this paper has been made available under the University of Oxford's Open Access Publications Policy, and a CC BY public copyright licence has been applied.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP